SCD - Latest News
LMP Capital and Income Fund Inc. (SCD), operates in Financial Services / Asset Management - Income, trades on NYSE.
Market capitalization stands near $5.17B.
The article list below shows the most recent SCD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent SCD Headlines
Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol
prnewswire.com - Jul 16, 2026
Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticles (LPNs) novel formulation of Aramchol that penet
10 Best CEFs This Month: Average Yield Of Near 10% (June 2026)
seekingalpha.com - Jun 27, 2026
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9. 8% plus yield and ne
SCD: Gets The Job Done But Not The Most Efficient Income Fund
seekingalpha.com - Jun 18, 2026
LMP Capital and Income Fund maintains a 9. 2% yield, with management expressing confidence in sustaining current distributions through August.
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5--11, at the European Hematology Association Congress and Announces Additional Global Regulatory Su
gurufocus.com - Jun 11, 2026
[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVYÂ (exagamglogene au
10 Best CEFs This Month: Average Yield Of 9% Plus (May 2026)
seekingalpha.com - May 23, 2026
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9% plus yield and nearl
Frequently asked SCD news questions
- What is the latest SCD news headline?
- The most recent SCD headline (Jul 16, 2026) is "Galmed Announces the Breakthrough Development of Novel LNP Cardiac Targeted Formulation of its SCD1 inhibitor, Aramchol". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the SCD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What SCD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual SCD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.